Cargando…
Convergent validity of EQ-5D with core outcomes in dementia: a systematic review
OBJECTIVES: To explore through a systematic review, the convergent validity of EQ-5D (EQ-5D-3L and EQ-5D-5L (total score and dimensions)) with core outcomes in dementia and investigate how this may be impacted by rater-type; with the aim of informing researchers when choosing measures to use in deme...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675120/ https://www.ncbi.nlm.nih.gov/pubmed/36403046 http://dx.doi.org/10.1186/s12955-022-02062-1 |
_version_ | 1784833300029767680 |
---|---|
author | Hussain, Hannah Keetharuth, Anju Rowen, Donna Wailoo, Allan |
author_facet | Hussain, Hannah Keetharuth, Anju Rowen, Donna Wailoo, Allan |
author_sort | Hussain, Hannah |
collection | PubMed |
description | OBJECTIVES: To explore through a systematic review, the convergent validity of EQ-5D (EQ-5D-3L and EQ-5D-5L (total score and dimensions)) with core outcomes in dementia and investigate how this may be impacted by rater-type; with the aim of informing researchers when choosing measures to use in dementia trials. METHODS: To identify articles relevant to the convergent validity of EQ-5D with core dementia outcomes, three databases were electronically searched to September 2022. Studies were considered eligible for inclusion within the review if they included individual level data from people with dementia of any type, collected self and/or proxy reported EQ-5D and collected at least one core dementia outcome measure. Relevant data such as study sample size, stage of dementia and administration of EQ-5D was extracted, and a narrative synthesis was adopted. RESULTS: The search strategy retrieved 271 unique records, of which 30 met the inclusion criteria for the review. Twelve different core outcome measures were used to capture dementia outcomes: cognition, function, and behaviour/mood across the studies. Most studies used EQ-5D-3L (n = 27). Evidence related to the relationship between EQ-5D and measures of function and behaviour/mood was the most robust, with unanimous directions of associations, and more statistically significant findings. EQ-5D dimensions exhibited associations with corresponding clinical outcomes, whereby relationships were stronger with proxy-EQ-5D (than self-report). CONCLUSION: Measuring health-rated quality of life in dementia populations is a complex issue, particularly when considering balancing the challenges associated with both self and proxy report. Published evidence indicates that EQ-5D shows evidence of convergent validity with the key dementia outcomes, therefore capturing these relevant dementia outcomes. The degree of associations with clinical measures was stronger when considering proxy-reported EQ-5D and differed by EQ-5D dimension type. This review has revealed that, despite the limited targeted psychometric evidence pool and reliance on clinical and observational studies, EQ-5D exhibits convergent validity with other dementia outcome measures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-022-02062-1. |
format | Online Article Text |
id | pubmed-9675120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96751202022-11-20 Convergent validity of EQ-5D with core outcomes in dementia: a systematic review Hussain, Hannah Keetharuth, Anju Rowen, Donna Wailoo, Allan Health Qual Life Outcomes Review OBJECTIVES: To explore through a systematic review, the convergent validity of EQ-5D (EQ-5D-3L and EQ-5D-5L (total score and dimensions)) with core outcomes in dementia and investigate how this may be impacted by rater-type; with the aim of informing researchers when choosing measures to use in dementia trials. METHODS: To identify articles relevant to the convergent validity of EQ-5D with core dementia outcomes, three databases were electronically searched to September 2022. Studies were considered eligible for inclusion within the review if they included individual level data from people with dementia of any type, collected self and/or proxy reported EQ-5D and collected at least one core dementia outcome measure. Relevant data such as study sample size, stage of dementia and administration of EQ-5D was extracted, and a narrative synthesis was adopted. RESULTS: The search strategy retrieved 271 unique records, of which 30 met the inclusion criteria for the review. Twelve different core outcome measures were used to capture dementia outcomes: cognition, function, and behaviour/mood across the studies. Most studies used EQ-5D-3L (n = 27). Evidence related to the relationship between EQ-5D and measures of function and behaviour/mood was the most robust, with unanimous directions of associations, and more statistically significant findings. EQ-5D dimensions exhibited associations with corresponding clinical outcomes, whereby relationships were stronger with proxy-EQ-5D (than self-report). CONCLUSION: Measuring health-rated quality of life in dementia populations is a complex issue, particularly when considering balancing the challenges associated with both self and proxy report. Published evidence indicates that EQ-5D shows evidence of convergent validity with the key dementia outcomes, therefore capturing these relevant dementia outcomes. The degree of associations with clinical measures was stronger when considering proxy-reported EQ-5D and differed by EQ-5D dimension type. This review has revealed that, despite the limited targeted psychometric evidence pool and reliance on clinical and observational studies, EQ-5D exhibits convergent validity with other dementia outcome measures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-022-02062-1. BioMed Central 2022-11-19 /pmc/articles/PMC9675120/ /pubmed/36403046 http://dx.doi.org/10.1186/s12955-022-02062-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Hussain, Hannah Keetharuth, Anju Rowen, Donna Wailoo, Allan Convergent validity of EQ-5D with core outcomes in dementia: a systematic review |
title | Convergent validity of EQ-5D with core outcomes in dementia: a systematic review |
title_full | Convergent validity of EQ-5D with core outcomes in dementia: a systematic review |
title_fullStr | Convergent validity of EQ-5D with core outcomes in dementia: a systematic review |
title_full_unstemmed | Convergent validity of EQ-5D with core outcomes in dementia: a systematic review |
title_short | Convergent validity of EQ-5D with core outcomes in dementia: a systematic review |
title_sort | convergent validity of eq-5d with core outcomes in dementia: a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675120/ https://www.ncbi.nlm.nih.gov/pubmed/36403046 http://dx.doi.org/10.1186/s12955-022-02062-1 |
work_keys_str_mv | AT hussainhannah convergentvalidityofeq5dwithcoreoutcomesindementiaasystematicreview AT keetharuthanju convergentvalidityofeq5dwithcoreoutcomesindementiaasystematicreview AT rowendonna convergentvalidityofeq5dwithcoreoutcomesindementiaasystematicreview AT wailooallan convergentvalidityofeq5dwithcoreoutcomesindementiaasystematicreview |